NRx Pharmaceuticals Merger Investigation Form

An investigation has commenced into the fairness of the 2021 de-SPAC merger of NRx Pharmaceuticals Inc. (f/k/a Big Rock Partners Acquisition Corp.) (“NRXP” or the "Company") (NASDAQ: NRXP) . Shortly after the NRXP 2021 de-SPAC merger closed, NRXP stock began spiraling downwards.

The NRXP de-SPAC merger investigation concerns this transaction unfairly harmed stockholders and whether all material facts were properly disclosed to stockholders.

To receive more information, please fill out the form.

Submit Your Information

This submission does not create an attorney-client relationship. By submitting your information, you are giving us your express consent to contact you by email, text message, SMS, or call you by telephone.

Privacy Policy